ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

ISTH 2021 Congress

July 17-21, 2021. Philadelphia, PA.

View by Title View by Number View Themes
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
  • Abstract Number: PB1203

    Machine Learning and Algorithmic Diagnosis Identification of PatientsTreated by Direct Oral Anticoagulants Using Medico-administrative Databases

    J. Emmerich1, A. Chekroun-Martinot2, C. Petri3, R. Sigogne2, L. Perray2, M. Maravic4

  • Abstract Number: PB0967

    Machine Learning-guided Analysis of Adult and Cord Platelet Adhesion Dynamics

    J. Sheriff1, P. Wang1, P. Zhang1, Z. Zhang1, W. Bahou1, Y. Deng1, D. Bluestein1

  • Abstract Number: PB0388

    Main Blood Serum Metabolites Responsible for the Discrimination of Hospitalized Patients with Moderate Symptoms with or without COVID-19

    L. Martins1, S. Martins2, E. Braga1, D. Stanisic1, S. Montalvão2, L. Da Silva2, S. Huber2, C. Bacchin2, N. Santos2, T. Diaz3, C. Wroclawski4, C. Filho4, L. Tasic2, J. Annichino-Bizzacchi2

  • Abstract Number: OC 53.1

    Major Adverse Cardiovascular Events Are a Major Cause of Morbidity after Recovery from Immune Thrombotic Thrombocytopenic Purpura

    M. Brodsky1, S. Selvakumar2, L. Yanek1, S. Hussain1, A. Moliterno1, R. Brodsky1, S. Chaturvedi1

  • Abstract Number: PB0734

    Malignant Clonal Cell Proliferation in Multiple Myeloma and the Hypercoagulable State

    T. Indran1, G. Gerotziafas2, J. Fareed3, A. Spencer1

  • Abstract Number: PB0131

    Management of a Non-vitamin K Antagonist Oral Anticoagulant Associated Bleeding – A Case Report

    R. Pombal1, S. Lopes1, L. Vieira1, R. Neto1, H. Gomes1, M. Figueiredo1

  • Abstract Number: PO136

    Management of a Patient with Hemorragic and Thrombotic Risk Factors, a Brazilian Case Report

    N.d.F. Centuriao1, A.A.R. Villarinho1, V.F. Aranda1, D.H.C. Campelo1, R.M.C. Penteado1, J.C.d.C. Guerra1

  • Abstract Number: PO147

    Management of Acquired Hemophilia A: A Case-report

    J. Cabral1, M. Afonso1, L. Costa2, B. Malheiro3, M. Calheiros1, A.P. Barbosa1, C. Calaza1, M. Majar3, G. Carvalho3, A. Marques1

  • Abstract Number: PO180

    Management of Anticoagulation Therapy in Patients with Idiopathic Mondor’s Disease

    G. Sottilotta1, M.G. Fava2, L. Turano3, F. Luise4, G.M. Nicolo'5, V. Oriana1, A. Piromalli4

  • Abstract Number: PB0790

    Management of Antithrombotic Treatment and Thrombohaemorragic Events in Children under Berlin Heart Excor Devices

    M. Arguello-Tomas1, R. Gomez-Antonio1, M.J Santiago1, G. Pérez Rus1,2, J.L. Diez-Martin2,3,1, C. Pascual Izquierdo1,3

  • Abstract Number: PB0081

    Management of Bleeding and Urgent Invasive Procedures in Patients Treated with Direct Oral Anticoagulants: An Observational Study over a Five-year Perio

    A. Pontis1,2, A. Mansour2,3, A. Maurice3, C. Rousseau4, F. Nédelec-Gac1, P. Guéret1, L. Soulat5, P. Jégo6, C. Ecoffey3, I. Gouin-Thibault1,2,7

  • Abstract Number: PB1092

    Management of Cancer Associated Thrombosis in France: A National Survey in Vascular Disease and Supportive Care Specialists

    I. Mahé1, C. Chapelle2, S. Laporte3, L. Bertoletti4, P. Mismetti4, G. Meyer5, D. Mayeur6, G. Mahé7, F. Couturaud8

  • Abstract Number: PB0296

    Management of Clot in Transit in a Postpartum COVID-19 Patient

    A. Peruri1, A. Kadl1, C. Ennen1, L. Wilkins1, R. Ramcharitar1, N. Teman1, A. Sharma1, A. Mihalek1, L. Man1

  • Abstract Number: PB0203

    Management of COVID-19 Related Venous Thromboembolism – Data from Ljubljana Registry

    G. Tratar1, A. Mavri1, T. Vižintin Cuderman1, N. Vene1, M. Žitko1, A. Rehberger Likozar1

  • Abstract Number: PB0789

    Management of Iliofemoral Deep Vein Thrombosis (DVT) in Pediatric Patients in the Context of May-Thurner Syndrome (MTS)

    V. Patel1, N. Stein2, F. Elias3, A.K. Chan4, M. Bhatt4

  • Abstract Number: PB0659

    Management of Infusion Reactions: Lessons from the Phase 3 HOPE-B Gene Therapy Trial of Etranacogene Dezaparvovec in Adults with Hemophilia B

    M. Recht1, F.W. Leebeek2, W. Miesbach3, N.S Key4, S. Lattimore1, G. Castaman5, E.K. Sawyer6, D. Cooper6, V. Colletta6, S.W. Pipe7, HOPE-B Investigators

  • Abstract Number: PB0043

    Management of Intentional Low Molecular Weight Heparin Overdose: The McMaster University Experience

    C. Lu1, M.A Crowther1, P.L Gross1,2, S.M Bates1,2, S. Mithoowani1

  • Abstract Number: LPB0077

    Management of Localized Intravascular Coagulopathy with Rivaroxaban in Children with Venous Malformations: Report of 6 Cases

    F.B. Belen Apak1, F. Nabili2, F. Sarialioglu1

  • Abstract Number: OC 57.1

    Management of Patients with Venous Thromboembolism and a High Recurrence Risk Estimated by the Vienna Prediction Model

    L. Eischer1, H. Šinkovec2, P. Gressenberger3, T. Gary3, M. Brodmann3, G. Heinze2, P.A. Kyrle1, S. Eichinger1.

  • Abstract Number: LPB0047

    Management of Peripartum Anticoagulation in Women with Venous Thromboembolism: An International Survey of Clinical Practice

    C. Simard1, I. Malhamé2, E. Rey3, M.P. Carson4, V. Tagalakis5

  • Abstract Number: PO179

    Management of Venous Thrombosis in Non-Hodgkin Lymphoma

    V. Musteata1

  • Abstract Number: OC 69.1

    Management Practices of Catheter-related Arterial Thrombosis in Children and Neonates: Results of a Multinational Survey

    M. Rizzi1, C.H. Van Ommen2, M. Albisetti3, On behalf of the International Pediatric Thrombosis Network (IPTN)

  • Abstract Number: NUR 01.5

    Managing Outpatients on Vitamin K Antagonists (VKAs) during the COVID-19 Pandemic in a Tertiary Referral Hospital

    C. O'Leary1,1, V. Silvari1, C. Browne1, P. O'Flynn1, P. Chappell1, C. Duggan1, M. Crowley1

  • Abstract Number: OC 17.1

    Mapping Gene and Gene Pathways Associated with Coronary Artery Disease: A CARDIoGRAM Exome and Multi-ancestry UK Biobank Analysis

    P. Hariharan1, J. Dupuis2

  • Abstract Number: LPB0100

    Mapping Prothrombin Binding on Pseutarin C by Site-directed PEGylation

    F.I. Ustok1, J.A. Huntington1

  • Abstract Number: PB0966

    MAS9 – A Novel Small Molecule Inhibitor of the CLEC-2-Podoplanin Interaction

    M.A. Sowa1, J. van Groningen2, Y. Di3, J.M. Gibbins1, Á. García4, A.Y. Pollitt1

  • Abstract Number: PB0031

    Mass Cytometry Analysis of Venous Thrombi Demonstrates Key Roles for VWF Interactions in Inflammation-associated DVT

    S.J. Choi1, M. Cormier1, L. Rapkin2, C. Hindmarch3, D. Lillicrap1

  • Abstract Number: PB1274

    May-Thurner Syndrome-associated Deep Vein Thrombosis: Is Oral Anticoagulation the Novel Approach?

    F.A. Lo1

  • Abstract Number: PB0351

    Measurement of Factor VIII in the Presence of Emicizumab Is dependent on the chromogenic assay selected for use

    M. Byrne1, M. Doyle1, K. Ryan1, M. Lavin1, J.S O'Donnell1, N.M O'Connell1

  • Abstract Number: OC 51.4

    Measurement of von Willebrand Factor Levels via Fiber Optic-surface Plasmon Resonance

    B. Calcoen1, C. Dekimpe1, M. Jacquemin2, C. Tersteeg1, K. Vanhoorelbeke1, S. De Meyer1

  • Abstract Number: PB0679

    Measuring the Chromogenic FVIII Mimetic Activity of the New Bispecific Antibody, Mim8, in Artificially Spiked Severe Haemophilia A Plasma

    A. Bowyer1, M. Ezban2, S. Kitchen1

  • Abstract Number: PB0680

    Measuring the FVIII Mimetic Activity of the New Bispecific Antibody, Mim8, in Severe Haemophilia A Plasma Using APTT and One-stage FVIII Assays

    A. Bowyer1, M. Ezban2, S. Kitchen1

  • Abstract Number: PO132

    Mechanical Prosthetic Valve Thrombosis in COVID-19 Infection: Case Report

    N. Diaconu1, D. Lupu1, T. Cuzor1, A. Grosu1

  • Abstract Number: LB 02.3

    Mechanism of the development of thrombotic thrombocytopenia in Covid-19 infected patients and after vaccination

    T.H. Nguyen1,2, L.-Y. Chen1,3, N. Khan4,5, A. Lindenbauer6, D. Heinrich4,2

  • Abstract Number: OC 22.4

    Mechanisms Coupling Fibrinogen to Colitis Pathogenesis

    B.K. Sharma1, R. Kudira2, L. Rosenfeldt1, B. Gourley3, O. Milburn4, D. Haslam4, M. Watanabe-Chailland5, L. Romick-Rosendale5, M. Flick6, J. Palumbo1

  • Abstract Number: PB0959

    Medium Plate Volume as a Predictor of Plate Engraftment Time in Patients with Bone Marrow Transplant

    J.A. Avila Rueda1, C. Duboscq1, J. Ceresetto1, S. Palmer1, K. Oliveros1, S. Rivarola1, A.M. Cantillo1, M. Carreras1, L. Zapata1, M.C. Sernaque1, N. Flegler1, O.R. Oscar Rabinovich1, C. Shanley1, M. Quarchioni1, E. Bullorsky1, G. Stemmelin1

  • Abstract Number: PB0836

    Melanoma Triggers Severe Thrombotic Thrombocytopenic Purpura and Results in a High Mortality Rate in adamt13-/- Zebrafish

    L. Zheng1, L. Cao2, X.L. Zheng1

  • Abstract Number: PB0585

    Mental Health Status of Hemophilia Carriers in China

    D. Cui1, Q. Hu1

  • Abstract Number: PB0856

    Minimal Role of the Alternative Pathway in Complement Aactivation by HIT Immune Complexes

    A. Barnes1, S. Khandelwal1, S. Sartoretto1, S. Myoung1, S. Francis1, G. Lee1, L. Rauova2, D. Cines3, J. Skare4, B. Garcia5, G. Arepally1

  • Abstract Number: PB0024

    miR-19a-3p Predicts Stroke Severity and miR-186-5p Might Be a Diagnostic Biomarker in Ischemic Stroke Patients with Hyper Platelet Reactivity

    C. Eyileten1, D. Jakubik1, J. Jarosz-Popek1,2, P. Czajka1, M. Wolska1, A. Fitas1, A. Nowak1, Z. Wicik3, D. Mirowska-Guzel1, A. Członkowska4, M. Postuła1

  • Abstract Number: PO183

    Misdiagnosing Protein C and Protein S Deficiency

    C. Peixoto1, Á. Beleza1, M. Galvão1, A. Freixo1, T. Quaresma1, J. Amorim1, M.M. Deveza1

  • Abstract Number: PB0453

    Mitigation of Injection Site Reactions after Subcutaneous Administration of Dalcinonacog Alfa (DalcA) in Hemophilia B Using Preclinical Models

    N. Le Moan1, L. Kelly1, E. Merle2, P. Descargues2, N. Gaudenzio2, H. Gagnon3, A. Chatterji1, G.E. Blouse1

  • Abstract Number: PB0894

    Modelling Studies to Characterize a Novel Disease-causing Variant in the GP1BA Gene Related to Bernard Soulier Syndrome

    D.M Primrose1, A.I. Woods2, M.F Alberto3, J. Paiva3, M. Asencio3, M.M Casinelli3, A.N Blanco3, A. Sánchez-Luceros3,2

  • Abstract Number: PB0949

    Modern Diagnosis of von Willebrand Disease in Children in Russia: Experience in Centralized Diagnostics

    A. Poletaev1, E. Seregina1,2, D. Fedorova1, P. Zharkov1

  • Abstract Number: PB0974

    Modification of Platelet Characteristics and Hemostasis in Children with Inflammatory Bowel Diseases under Hyperbaric Oxygenation

    A. Popovicheva1, A. Martusevich1, E. Fedulova1, I. Neshchetkina1

  • Abstract Number: OC 71.4

    Modulation of the Procoagulant and Cytotoxic Effects of Histones by Glycosaminoglycans

    N. Sharma1,2, S. Sohrabipour1, D. Dwivedi1,2, P. Liaw1,2

  • Abstract Number: PB0942

    Molecular Heterogeneity in von Willebrand Disease in North Indian Patients

    R. Sharma1, M. Jamwal1, N. Kumar1, H.K. Senee1, C. Hans1, D. Bansal1, A. Trehan1, P. Malhotra1, R. Das1, J. Ahluwalia1

  • Abstract Number: LPB0111

    Molecular Interactions of Coagulation Factor XIII B Subunit

    K. Pénzes1, B. Bécsi2, F. Erdődi2, L. Muszbek1

  • Abstract Number: PB0063

    Monitoring Heparin: Stability of Two Different Anti-Xa Assays in Citrated vs CTAD Tubes

    T. Sinegre1, M. Gremillet1, V. Fourneyron1, M. Tillier1, A. Trayaud1, L. Talon1, A. Lebreton1

  • Abstract Number: PB0694

    Monitoring Rare Bleeding Disorders and their Response to Therapeutic Treatments with a Microchip Flow-chamber Assay

    P. Acuña1, E. G. Arias-Salgado1, E. Monzón Manzano1, M. Martín Salces1, M.T. Álvarez Román1, M.I. Rivas Pollmar1, S. García Barcenilla1, T. Cebanu1, E. Gonzalez Zorrilla1, N. Butta1, V. Jiménez Yuste1

  • Abstract Number: OC 77.1

    Monocyte-macrophage Synthesis of FVII Contributes to the Development of Atherosclerosis

    R. Wolz1, W. Ruf1,2

  • Abstract Number: LPB0112

    Monocytes Expose Factor XIII-A and Stabilize Thrombi against Fibrinolytic Degradation

    F. Alshehri1,2

  • Abstract Number: PB0461

    Monocytes Express Different Cytokines upon Stimulations with a Variety of FVIII but Not FIX Concentrates

    S. Scatigna1, A. Orlowski1, E. Salzmann-Manrique1, C. Königs1, A. Schmidt1

  • Abstract Number: PB0462

    Monocytes Show Differences in Cytokine Expression after Stimulation with FVIII Concentrates Compared to FIX or MOG

    S. Scatigna1, A. Orlowski1, E. Salzmann-Manrique1, C. Königs1, A. Schmidt1

  • Abstract Number: OC 68.1

    Morphological and Functional Alterations in Endothelial Colony-forming Cells from Recovered COVID-19 Patients

    J. Davila-Moreno1,2, V. Manuel-Domínguez1, A. Chávez-González3, A. Majluf-Cruz1, J.A. Alvarado-Moreno1

  • Abstract Number: PB0150

    Multi-organ Vascular Defects and General Morphological Changes in a Murine Model of SARS CoV-2 Infection

    M. Paidas1, A. Mohamed1, A. Saad2, A. Jayakumar1

  • Abstract Number: OC 19.1

    Multi-phenotype Analysis of Hemostatic Factors with Venous Thromboembolism Reveals Novel Genetic Associations

    G. Temprano-Sagrera1, P.S de Vries2, M. Martín-Bórnez1, S.M Damrauer3,4,5, N.L Smith6,7,8, M. Sabater-Lleal1, on behalf the CHARGE and INVENT Consortia.

  • Abstract Number: OC 45.1

    Multicenter Performance Evaluation and Reference Range Determination for the Quantitative Assessment of Factor XI Activity by One-stage Factor Assay on the Cobas t 711 Analyzer

    M. Büchsel1, J. Creaghan2, U. Geisen1, P. Jilma3, R. Jones2, S. Kitchen2, G. Rozsnyai4, P. Quehenberger3

  • Abstract Number: PB0366

    Multicenter Performance Evaluation and Reference Ranges for the Quantitative Determination of Factor XII Activity by One-stage Factor Assay on the Cobas t 711 Analyzer

    M. Büchsel1, J. Creaghan2, U. Geisen1, P. Jilma3, R. Jones2, S. Kitchen2, G. Rozsnyai4, P. Quehenberger3

  • Abstract Number: PB0133

    Mutagenesis Study Reveals Factor X Gla-domain Residues Critical for Initiation of the Clotting Cascade

    D. Paul1, S.M. Medfisch1, R.C. Bailey1, J.H. Morrissey1

  • Abstract Number: LPB0065

    Mutation of Sortase A Cleavage Site and Potential Impact on Human Plasminogen Binding by PAM

    B. Readnour1, Y. Ayinuola1, V. Ploplis1, F. Castellino1

  • Abstract Number: PB0905

    Mutations at p.C1190 in VWF D3 Retain VWF in the ER in VWD 2A Patient-derived ECFCs

    I. Van Moort1, P.E. Bürgisser1, M.W. Swinkels1, S. Yildiz1, F. Atiq1, F.W. Leebeek1, R. Bierings1, for the SYMPHONY consortium

  • Abstract Number: OC 01.3

    Myeloid Par2 Deficiency Protects Mice during IAV Infection

    R.C. Gunther1, E. Camerer2, N. Mackman1, S. Antoniak1

Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2022 John Wiley & Sons, Inc. All Rights Reserved.
Wiley